Search results - 264 results

Development and validation of a microfluidic multiplex immunoassay for the determination of levels and avidity of serum antibodies to tetanus, diphtheria and pertussis antigens.

maladies Ziekten en gezondheid in kaart brengen Service:  Réponse immunitaire Immuunrespons Immune response Manuscript versions:  DOI:  https://pubmed.ncbi.nlm.nih.gov/35248526/ Version:  Published Full text ...

Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerPurpose:Experimental Design:Results:Conclusions:

Publication Type: Peer reviewed scientific article Authors: Debie, Yana; Van Audenaerde, Jonas R.M.; Vandamme, Timon; Croes, Lieselot; Teuwen, Laure-Anne; Verbruggen, Lise; Vanhoutte, Greetje; Marcq, Elly; Verheggen, Lisa; Le Blon, Debbie; Peeters, Bart; ...

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.

gezondheid in kaart brengen Service:  Réponse immunitaire Immuunrespons Immune response Manuscript versions:  DOI:  https://pubmed.ncbi.nlm.nih.gov/35260578/ Version:  Published Full text language:  English ...

Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients.

des maladies Ziekten en gezondheid in kaart brengen Service:  Réponse immunitaire Immuunrespons Immune response Manuscript versions:  DOI:  https://pubmed.ncbi.nlm.nih.gov/34554629/ Version:  Published ...

Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.

Maladies virales Virale ziekten Viral diseases Réponse immunitaire Immuunrespons Immune response Manuscript versions:  Full text access:  Public Access Full text language:  English Category:  A2 FOS ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study

explained by socioeconomic differences in the prevalence of chronic diseases. Further research is needed to explore if this difference could be related to a lower immune response of people with certain ...

The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff- study protocol description and presentation of preliminary findings on symptoms.

infections (ARI). However, little is known, about the impact of a previous or current infection on the other in terms of susceptibility, immune response, and clinical course. The aim of the “Prior Infection ...

Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.

# 2021-000673-83). Health Topics:  Health and disease monitoring Surveillance de la santé et des maladies Ziekten en gezondheid in kaart brengen Service:  Réponse immunitaire Immuunrespons Immune response Manuscript ...

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.

rituximab, resulting in a 2-week hospital admission. CONCLUSION: The BNT162 b2 vaccine is well-tolerated in cancer patients under active treatment. However, the antibody response of immunized cancer patients ...

QR code

QR code for this page URL